Global VPM Tuberculosis Bcg Based Vaccine For Prevent Covid Market Size, Share and Trends Analysis Report, By Product Type (0.5ml Package, 1ml Package, 2ml Package, Other), By Application (0-5 Years Old, 5-18 Years Old, 18-45 Years Old, 45-65 Years Old, Above 65 Years Old), Forecast (2022-2028)

The global VPM tuberculosis BCG-based vaccine for preventing covid market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The significant rise in initiatives to vaccinate population by government is anticipated to drive the growth of the global VPM tuberculosis BCG-based vaccine for preventing covid market. A new initiative by Max Planck Institute could produce immediate results because the phase III trial of VPM1002 could start in 2,000 people in Germany in all hospitals. Shortly thereafter, SII begins trials in India as well. Phase III clinical trials include up to 3,000 participants with the condition. The trials will be performed on healthcare workers to see the effectiveness of the vaccine as a means of preventing the novel coronavirus, as well as in older patients to determine its effectiveness in reducing clinical complications.

 

The BCG vaccine prevents severe forms of tuberculosis in children, and diversion of local material may result in newborns being vaccinated, leading to an increase in the number of infections and deaths in TB. In the absence of evidence, the WHO does not recommend BCG vaccination to prevent COVID-19. WHO continues to recommend BCG immunization of newborns in countries or areas with a high incidence of TB.For instance,in April 2020, the WHO revised the ongoing review of the evidence for a large scientific database and clinical trial sites, using English, French, and Chinese search terms COVID-19, coronavirus, SARS-CoV-2, and BCG.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-VakzineProjekt Management, and Serum Institute of India,among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global VPM Tuberculosis Bcg Based Vaccine For Prevent Covid Market Report by Segment

By Product Type

• 5ml Package
• 1ml Package
• 2ml Package
• Other

By Application

• 0-5 Years Old
• 5-18 Years Old
• 18-45 Years Old
• 45-65 Years Old
• Above Years Old

 

GlobalVPM Tuberculosis Bcg Based Vaccine For Prevent Covid Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa